tbResList Print — TBE Terminalia bellirica

Filters: qv=427, qv2=%, rfv=%

Product

TBE Terminalia bellirica
Description: <p>Terminalia bellirica: The fruit extract contains multiple active constituents, including gallic acid, ellagic acid, corilagin, ethyl gallate, galloyl glucose, chebulagic acid and arjunolic acid.</p>
<table>
<tr>
<td>Evidence level</td>
<td>Primarily in vitro and animal evidence; limited human clinical evidence</td>
</tr>
<tr>
<td>Main research areas</td>
<td>Inflammation, oxidative stress, metabolic effects, hepatoprotection and cancer</td>
</tr>
<tr>
<td>Primary preparation</td>
<td>Fruit extract</td>
</tr>
<tr>
<td>Key constituents</td>
<td>Gallic acid, ellagic acid, corilagin, chebulagic acid, ethyl gallate and related hydrolysable tannins</td>
</tr>
</table>

Pathway results for Effect on Cancer / Diseased Cells

Total Targets: 0

Pathway results for Effect on Normal Cells

Redox & Oxidative Stress(tgid=1)

NRF2↑, 1,   ROS↓, 1,   TAC↑, 1,  

Core Metabolism/Glycolysis(tgid=4)

AMPK↑, 1,  

Cell Death(tgid=5)

Akt↑, 1,   MAPK↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

Inflam↓, 1,   NF-kB↓, 1,  
Total Targets: 8

Research papers

Year Title Authors PMID Link Flag
2018Terminalia bellirica (Gaertn.) Roxb. Extract and Gallic Acid Attenuate LPS-Induced Inflammation and Oxidative Stress via MAPK/NF-κB and Akt/AMPK/Nrf2 PathwaysMiori TanakaPMC6250009https://pmc.ncbi.nlm.nih.gov/articles/PMC6250009/0